Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
about
The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia.FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanismDiscovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML.MZH29 is a novel potent inhibitor that overcomes drug resistance FLT3 mutations in acute myeloid leukemia.Role and regulation of microRNAs targeting BTK in acute myelogenous leukemia.Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia.
P2860
Q37706488-7D1EE3BA-0183-4878-8440-17B330EB3EFFQ38675400-509430C4-F865-4E2B-B4EF-D811050D2E56Q38815360-FD59C295-BDCB-4265-B67D-802F1D2D9F48Q41355614-645A2B02-DB90-4BED-A5E0-32EB69311B15Q48282223-DEB0D503-BF99-47CC-908F-6E64F75BF386Q50054874-8B51F25B-035E-4F83-82AD-57DA6D8786E1Q50131810-9D235014-17C5-43D9-B81E-8796556AD40A
P2860
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
@en
type
label
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
@en
prefLabel
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
@en
P2093
P2860
P356
P1433
P1476
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
@en
P2093
E L Weisberg
J D Griffin
P2860
P2888
P304
P356
10.1038/LEU.2015.175
P577
2015-07-03T00:00:00Z
P6179
1031697455